Skip to main content
Clinical Trials/NCT03079856
NCT03079856
Completed
N/A

Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER

University of Michigan1 site in 1 country63 target enrollmentOctober 9, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Drug Use
Sponsor
University of Michigan
Enrollment
63
Locations
1
Primary Endpoint
Change in days substance use
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This project will develop a technology-augmented HIV and substance use risk reduction intervention for delivery in the Emergency Department, a medical setting where at-risk emerging adults who use drugs and engage in HIV-related risk behaviors are likely to present.

Detailed Description

Research regarding substance use (including illicit drugs and non-medical use of prescription drugs) and HIV-related sexual risk behaviors (HIV SRBs; e.g., inconsistent condom use, multiple partners, sex while intoxicated; and prevention of injection drug use) among emerging adults (EAs; ages 18-25) has generally focused on alcohol use among college students from campus settings; however, substance use and HIV (and other associated Sexually Transmitted Infections) disproportionately occur among young people living in urban, low-resource communities, particularly individuals of racial minorities. The Emergency Department (ED) is a critical venue for accessing at-risk EAs engaging in substance use and HIV risk behaviors. Research shows high rates of substance use and HIV SRBs among EA patients in the ED, yet no intervention exists for EAs in this setting. The ED may be the only opportunity to intervene with these young people because EAs in urban, low-resource settings often lack a primary care provider during the transition from pediatric to adult medicine, may be un-insured or under-insured, and may not be involved in a traditional college campus setting. Further the use of technology (e.g., mobile phones) is relatively ubiquitous among this age group, and most prefer technology-based communication (e.g., text messaging or instant messaging via apps), therefore interventions for EAs may be enhanced by this type of technology. In this phase we will test a tailored intervention for EA patients in the ED focusing on reducing substance use and HIV SRBs, which will be enhanced through the use of mobile app notifications.

Registry
clinicaltrials.gov
Start Date
October 9, 2017
End Date
August 13, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erin Bonar

Assistant Professor of Psychiatry

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Medically stable
  • Mentally and physically able to consent
  • English-speaking
  • Between ages 18-25
  • Past-month substance use (including illicit drugs and/or non-medical prescription drug use) and inconsistent condom use in the past month
  • Ownership of a smartphone

Exclusion Criteria

  • ED presentation suicidality and/or acute psychosis, being in police custody, or present with psychological distress requiring intensive social work (e.g. sexual assault)
  • Patients with a significant other that they live with who is currently participating in study
  • Actively participating in another study
  • Participated in prospective and intervention development phases of the study
  • Do not wish to consent to audio-taping the in-person portion of the ED-based intervention session

Outcomes

Primary Outcomes

Change in days substance use

Time Frame: 2-months post baseline

60-day Timeline Follow-Back (TLFB) will be used to assess total days of any substance use.

Change in quantity of marijuana use

Time Frame: 2-months post baseline

60-day Timeline Follow-Back (TLFB) will be used to assess quantity of marijuana consumed.

Change in total alcohol consumption

Time Frame: 2-months post baseline

60-day Timeline Follow-Back (TLFB) will be used to assess quantity of alcohol consumed

Secondary Outcomes

  • Change in HIV risk behaviors(2-months post baseline)
  • Change in substance use consequences(2-months post baseline)

Study Sites (1)

Loading locations...

Similar Trials